Myositis interstitial lung disease and autoantibodies

Shire Chaudhry; Lisa Christopher-Stine

doi:10.3389/fmed.2023.1117071

Myositis interstitial lung disease and autoantibodies

Shire Chaudhry, Lisa Christopher-Stine

School of Medicine

Research output: Contribution to journal › Review article › peer-review

Abstract

The aim of this review is to examine and evaluate published literature associated with idiopathic inflammatory myopathies (IIM) and interstitial lung disease (ILD) based on myositis specific autoantibodies (MSA) and the potential clinical significance of each autoantibody subtype for the practicing clinician. The review is a comprehensive search of literature published in PubMed from the year 2005 and onward coinciding with the surge in the discovery of new MSAs. Additionally, we comment on recommended multidisciplinary longitudinal care practices for patients with IIM-ILD with regard to imaging and other testing. Treatment is not covered in this review.

Original language	English (US)
Article number	1117071
Journal	Frontiers in Medicine
Volume	10
DOIs	https://doi.org/10.3389/fmed.2023.1117071
State	Published - 2023

Keywords

interstitial lung disease
myositis
myositis specific autoantibodies
narrative review
pulmonary fibrosis

ASJC Scopus subject areas

General Medicine

Access to Document

10.3389/fmed.2023.1117071

Cite this

@article{d98f207043874fd591530df5805891e9,

title = "Myositis interstitial lung disease and autoantibodies",

abstract = "The aim of this review is to examine and evaluate published literature associated with idiopathic inflammatory myopathies (IIM) and interstitial lung disease (ILD) based on myositis specific autoantibodies (MSA) and the potential clinical significance of each autoantibody subtype for the practicing clinician. The review is a comprehensive search of literature published in PubMed from the year 2005 and onward coinciding with the surge in the discovery of new MSAs. Additionally, we comment on recommended multidisciplinary longitudinal care practices for patients with IIM-ILD with regard to imaging and other testing. Treatment is not covered in this review.",

keywords = "interstitial lung disease, myositis, myositis specific autoantibodies, narrative review, pulmonary fibrosis",

author = "Shire Chaudhry and Lisa Christopher-Stine",

note = "Funding Information: LC-S was supported by the Huayi and Siuling Zhang Discovery Fund. Publisher Copyright: Copyright {\textcopyright} 2023 Chaudhry and Christopher-Stine.",

year = "2023",

doi = "10.3389/fmed.2023.1117071",

language = "English (US)",

volume = "10",

journal = "Frontiers in Medicine",

issn = "2296-858X",

publisher = "Frontiers Media SA",

}

TY - JOUR

T1 - Myositis interstitial lung disease and autoantibodies

AU - Chaudhry, Shire

AU - Christopher-Stine, Lisa

PY - 2023

Y1 - 2023

N2 - The aim of this review is to examine and evaluate published literature associated with idiopathic inflammatory myopathies (IIM) and interstitial lung disease (ILD) based on myositis specific autoantibodies (MSA) and the potential clinical significance of each autoantibody subtype for the practicing clinician. The review is a comprehensive search of literature published in PubMed from the year 2005 and onward coinciding with the surge in the discovery of new MSAs. Additionally, we comment on recommended multidisciplinary longitudinal care practices for patients with IIM-ILD with regard to imaging and other testing. Treatment is not covered in this review.

AB - The aim of this review is to examine and evaluate published literature associated with idiopathic inflammatory myopathies (IIM) and interstitial lung disease (ILD) based on myositis specific autoantibodies (MSA) and the potential clinical significance of each autoantibody subtype for the practicing clinician. The review is a comprehensive search of literature published in PubMed from the year 2005 and onward coinciding with the surge in the discovery of new MSAs. Additionally, we comment on recommended multidisciplinary longitudinal care practices for patients with IIM-ILD with regard to imaging and other testing. Treatment is not covered in this review.

KW - interstitial lung disease

KW - myositis

KW - myositis specific autoantibodies

KW - narrative review

KW - pulmonary fibrosis

UR - http://www.scopus.com/inward/record.url?scp=85163997811&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85163997811&partnerID=8YFLogxK

U2 - 10.3389/fmed.2023.1117071

DO - 10.3389/fmed.2023.1117071

M3 - Review article

C2 - 37384043

AN - SCOPUS:85163997811

SN - 2296-858X

VL - 10

JO - Frontiers in Medicine

JF - Frontiers in Medicine

M1 - 1117071

ER -

Myositis interstitial lung disease and autoantibodies

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this